Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3750
+0.0150 (4.17%)
At close: May 15, 2025, 4:00 PM AEST
114.29%
Market Cap 46.26M
Revenue (ttm) 210.81K
Net Income (ttm) -3.10M
Shares Out 128.50M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 32,560
Average Volume 54,718
Open 0.3750
Previous Close 0.3600
Day's Range 0.3750 - 0.3775
52-Week Range 0.1700 - 0.6200
Beta n/a
RSI 40.05
Earnings Date May 28, 2025

About Cleo Diagnostics

Cleo Diagnostics Ltd, a medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company provides CleoDX pre-surgical triage tests which measures a combination of biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property and patents. The company was incorporated in 2021 and is based in Melbourne, Australia. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2021
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol COV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.